Tech Company Financing Transactions
Encodia Funding Round
Encodia, based in San Diego, secured $75 million from Deerfield Capital, Northpond Ventures and Alexandria Venture Investments.
Transaction Overview
Company Name
Announced On
1/29/2021
Transaction Type
Venture Equity
Amount
$75,000,000
Round
Series C
Investors
Deerfield Capital (Lead Investor) (Andrew ElBardissi)
Northpond Ventures (Lead Investor) (Sharon Kedar)
Proceeds Purpose
The company intends to use the funds to accelerate productization of its patented ProteoCode platform for broad use in life science research and subsequent clinical applications.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
11045 Roselle St. 120
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Not Recorded
Overview
Encodia is a rapidly growing platform company that is developing a new generation of protein analysis tools based on single-molecule protein sequencing. Our goal is to make protein sequencing easy and ubiquitous by using a novel reverse-translation technology that turns peptide sequences into DNA.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Technical Officer
Kevin Gunderson
President
Mark Chee
Vice President
Kenneth Kuhn
Browse more venture capital transactions:
Prev: 1/28/2021: Design Therapeutics venture capital transaction
Next: 1/29/2021: ClassDojo venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs